Abi Auer currently serves as the Sr. Director of National Accounts at Exelixis since August 2022. Previously, Abi held multiple roles at Optum from March 2018 to August 2022, including Sr. Director of Business Development & Industry Relations and Director of Specialty & Industry Relations. Prior experience includes serving as National Account Executive at Orexigen Therapeutics from May 2016 to March 2018 and various positions at Acorda Therapeutics, Inc., including Corporate Account Director and Regional Account Director for Managed Markets in the Southeast Region. Abi began the career as an Oncology District Manager at Schering-Plough Pharmaceuticals in 2007. Abi Auer earned a degree from the University of Florida between 1991 and 1996.
This person is not in any teams
This person is not in any offices